Journal
JAMA CARDIOLOGY
Volume 5, Issue 7, Pages 747-748Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jamacardio.2020.1329
Keywords
-
Categories
Ask authors/readers for more resources
This Viewpoint discusses whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
